Abstract The work describes novel functional bionanosystems for treatment and diagnostics on the basis of proteins, enzymes, polymeric coatings, and magnetic nanoparticles developed at Lomonosov Moscow State University Laboratory for Chemical Design of Bionanomaterials in collaboration with scientists from UNC Eshelman School of Pharmacy (USA). The properties of enzymes (superoxide dismutase, catalase, organophosphate hydrolase, and lysines of bacteriophages) and other drug molecules immobilized in polymeric complexes, as well as the methods for targeted drug delivery using cell-mediated systems and magnetic nanoparticles in in vitro and in vivo operating conditions, are discussed. Physical and chemical characteristics, including data on the functional properties of the nanoformulations, are obtained. The nanoformulations developed demonstrated high potential therapeutic efficacy for the treatment of central nervous system and brain diseases, inflammations (including inflammatory diseases of the eye), cancer and infectious diseases, neurotoxic injury, and others. The possibilities of remote control biochemical reactions using a nonheating low-frequency alternating magnetic field (AMF) for the controlled release of drugs are analyzed in the review. The experimental results of the AMF effects on bionanosystems containing magnetic nanoparticles, such as changing the catalytic activities of enzymes bound to magnetic nanoparticles and ‘disordering’ of the lipid bilayer in membranes, are considered.
magnetic nanoparticles1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Magnetic_nanoparticles

lysines                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lysine                

organophosphate               0.9999999977649168^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Organophosphate       

drug                          0.692992791518408^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Drug                  

enzymes                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Enzyme                

polymeric                     0.9999999981557721^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Polymer               

AMF                           0.8331127173514088^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Action_Message_Format 

remote control                0.9144519775365053^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Telepresence          

inflammations                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Inflammation          

drugs                         0.7283856079231177^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

enzymes                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Enzyme                

catalytic                     0.9999999901814363^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme                

AMF                           0.8331127173514088^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Action_Message_Format 

chemical                      0.9991208730514395^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Chemical_reaction     

Lomonosov Moscow State University1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Moscow_State_University

cancer                        0.9298560957125532^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Carcinogenesis        

efficacy                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Efficacy              

UNC                           0.9925448131482176^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/University_of_North_Carolina_at_Chapel_Hill

molecules                     0.9999973386383261^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Molecule              

magnetic nanoparticles        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Magnetic_nanoparticles

hydrolase                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hydrolase             

brain diseases                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Brain                 

neurotoxic                    0.9999999610477069^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Neurotoxicity         

bacteriophages                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Bacteriophage         

cell-mediated                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cell-mediated_immunity

infectious diseases           0.999999999994543^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Infection             

USA                           0.9999944602294559^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/United_States         

controlled release            0.9939779771570334^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Controlled_release    

eye                           0.9999295398315238^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Human_eye             

Pharmacy                      0.9999999999984084^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmacy              

enzymes                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Enzyme                

targeted drug delivery        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Targeted_drug_delivery

superoxide dismutase          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Superoxide_dismutase  

Eshelman                      0.9999999966660198^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Eshelman              

central nervous system        0.9999999968382554^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Central_nervous_system

magnetic nanoparticles        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Magnetic_nanoparticles

coatings                      0.9254313973747114^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Thin_film             

polymeric                     0.9999999981557721^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Polymer               

magnetic field                0.9962975818063879^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Magnetic_field        

catalase                      0.9029107832054358^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Catalase              

magnetic nanoparticles        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Magnetic_nanoparticles

biochemical reactions         0.9999936057463198^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Metabolism            

proteins                      0.9999999989516937^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protein               

inflammatory diseases         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Inflammation          

membranes                     0.9999999977505922^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cell_membrane         

lipid bilayer                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid_bilayer         

